RxDoctor Payments DataLook up a doctor →

SPEVIGO: payments to doctors

Payments that named SPEVIGO as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Total reported
$3.3M
Providers
9,788
Transactions
25,439
Average per transaction
$128

The per-transaction average — $128 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 9,788 providers the average total is $333, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
Boehringer Ingelheim$3,021,75592.6%
Boehringer Ingelheim International GmbH$165,4145.1%
LEO Pharma Inc.$70,5492.2%
Boehringer Ingelheim RCV GmbH & Co KG$5,8500.2%
← All drugs & devices